Breast Cancer

The American Cancer Society estimates that approximately 266,120 women will be diagnosed with breast cancer in the United States in 2018, and 40,920 will die from the disease. This disease represents the leading cause of death among all female cancer patients. Breast cancers encompass a heterogeneous array of tumor types that are classified according to their histological and molecular characteristics. To support your breast cancer research needs, ATCC provides breast cancer cell lines, a comprehensive Breast Cancer Resource Book, breast cancer tumor cell panels, and human primary and hTERT-immortalized mammary cells.

Breast Cancer Cell Lines

Tumors can arise from the ducts, lobules, or connective tissues of the breast. There are over 14 types of breast cancer. Thus, to generate the most known effective treatment options, investigators need in vitro research tools that represent the heterogeneity of breast cancers in vivo. ATCC has numerous breast cancer cell lines to support your research needs.

Browse the collection
Breast Cancer Resource Book

Breast Cancer Tumor Cell Panels

For optimal drug discovery studies, ATCC offers Tumor/Normal Matched Cell Line Pairs, Genetic Alteration Panels, and Panels by Molecular Signature. ATCC Tumor Cell Panels combine authenticated, well-characterized cell lines with mutation data from the Sanger Institute Catalogue of Somatic Mutations in Cancer (COSMIC) to create powerful tools for cancer research and drug discovery. 

Discover now

CellMatrix Basement Membrane Gel

The extracellular matrix is important for the maintenance of breast epithelium and is involved in oncogenic transformation. CellMatrix Gel may be used to promote spheroid formation in cancer cell lines in vitro, making it useful for the screening of anti-cancer drugs. 

Order now